LivingGLP1
Study S002385

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

Registration

Registration
NCT04135287
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
UNKNOWN
Enrollment
315
Start
2020-03-01
Primary completion
2023-03-01
Lead sponsor
Dasman Diabetes Institute
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:GLP-1 receptor agonist
Results posted
FALSE

Registered primary outcomes

  • HbA1c [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.